{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:34:27Z","timestamp":1794270867164,"version":"4.9.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772710"],"award-info":[{"award-number":["81772710"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172691"],"award-info":[{"award-number":["82172691"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473307"],"award-info":[{"award-number":["82473307"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation for Young Scholars from Jiangsu Province","award":["BK20241691"],"award-info":[{"award-number":["BK20241691"]}]},{"name":"Jiangsu Province Capability Improvement Project through Science\uff0c Technology and Education\uff0c Jiangsu Provincial Medical Key Discipline(Laboratory) Cultivation Unit","award":["JSDW202221"],"award-info":[{"award-number":["JSDW202221"]}]},{"name":"Jiangsu Provincial Healthcare Commission Scientific Research Grant Top Project","award":["M2020093"],"award-info":[{"award-number":["M2020093"]}]},{"name":"Jiangsu Provincial Social Development Project","award":["BE2023659"],"award-info":[{"award-number":["BE2023659"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05864-7","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T11:05:42Z","timestamp":1745924742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Unleashing the therapeutic potential of tumor-draining lymph nodes: spotlight on bladder cancer"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4970-1162","authenticated-orcid":false,"given":"Xin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"5864_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, Theodorescu D. Bladder cancer. Nat Rev Dis Primers. 2023;9:58.","journal-title":"Nat Rev Dis Primers"},{"key":"5864_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1053\/j.semnuclmed.2020.02.006","volume":"50","author":"C Seidl","year":"2020","unstructured":"Seidl C. Targets for therapy of bladder Cancer. Semin Nucl Med. 2020;50:162\u201370.","journal-title":"Semin Nucl Med"},{"key":"5864_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41585-023-00842-y","volume":"21","author":"E Grobet-Jeandin","year":"2024","unstructured":"Grobet-Jeandin E, Lenfant L, Pinar U, Parra J, Mozer P, Renard-Penna R, Thibault C, Roupret M, Seisen T. Management of patients with muscle-invasive bladder cancer with clinical evidence of pelvic lymph node metastases. Nat Rev Urol. 2024;21:339\u201356.","journal-title":"Nat Rev Urol"},{"key":"5864_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.eururo.2005.09.010","volume":"49","author":"P Marits","year":"2006","unstructured":"Marits P, Karlsson M, Sherif A, Garske U, Th\u00f6rn M, Winqvist O. Detection of immune responses against urinary bladder cancer in sentinel lymph nodes. Eur Urol. 2006;49:59\u201370.","journal-title":"Eur Urol"},{"key":"5864_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.0300-9475.2004.01423bp.x","volume":"59","author":"M Karlsson","year":"2004","unstructured":"Karlsson M, Marits P, Ban\u00e8r J, Sherif A, Th\u00f6rn M, Landegren U, Winqvist O. Detection of Immune responses in Sentinel nodes Draining Human urinary bladder Cancer. Scand J Immunol. 2004;59:637\u2013637.","journal-title":"Scand J Immunol"},{"key":"5864_CR6","doi-asserted-by":"crossref","unstructured":"Lei PJ, Pereira ER, Andersson P, Amoozgar Z, Van Wijnbergen JW, O\u2019Melia MJ, Zhou H, Chatterjee S, Ho WW, Posada JM et al. Cancer cell plasticity and MHC-II-mediated immune tolerance promote breast cancer metastasis to lymph nodes. J Exp Med 2023, 220.","DOI":"10.1084\/jem.20221847"},{"key":"5864_CR7","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1038\/s41467-018-04524-x","volume":"9","author":"R Alonso","year":"2018","unstructured":"Alonso R, Flament H, Lemoine S, Sedlik C, Bottasso E, Peguillet I, Premel V, Denizeau J, Salou M, Darbois A, et al. Induction of anergic or regulatory tumor-specific CD4(+) T cells in the tumor-draining lymph node. Nat Commun. 2018;9:2113.","journal-title":"Nat Commun"},{"key":"5864_CR8","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.it.2023.07.002","volume":"44","author":"S Suman","year":"2023","unstructured":"Suman S, Markovic SN. Melanoma-derived mediators can foster the premetastatic niche: crossroad to lymphatic metastasis. Trends Immunol. 2023;44:724\u201343.","journal-title":"Trends Immunol"},{"key":"5864_CR9","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.cell.2022.04.019","volume":"185","author":"NE Reticker-Flynn","year":"2022","unstructured":"Reticker-Flynn NE, Zhang W, Belk JA, Basto PA, Escalante NK, Pilarowski GOW, Bejnood A, Martins MM, Kenkel JA, Linde IL, et al. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis. Cell. 2022;185:1924\u201342. e1923.","journal-title":"Cell"},{"key":"5864_CR10","doi-asserted-by":"publisher","first-page":"816506","DOI":"10.3389\/fonc.2022.816506","volume":"12","author":"T Li","year":"2022","unstructured":"Li T, Liu T, Zhao Z, Xu X, Zhan S, Zhou S, Jiang N, Zhu W, Sun R, Wei F, et al. The Lymph Node Microenvironment May Invigorate Cancer cells with enhanced metastatic capacities. Front Oncol. 2022;12:816506.","journal-title":"Front Oncol"},{"key":"5864_CR11","doi-asserted-by":"publisher","first-page":"eabg3551","DOI":"10.1126\/sciimmunol.abg3551","volume":"6","author":"H du Bois","year":"2021","unstructured":"du Bois H, Heim TA, Lund AW. Tumor-draining lymph nodes: at the crossroads of metastasis and immunity. Sci Immunol. 2021;6:eabg3551.","journal-title":"Sci Immunol"},{"key":"5864_CR12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.tcb.2023.04.001","volume":"33","author":"NE Reticker-Flynn","year":"2023","unstructured":"Reticker-Flynn NE, Engleman EG. Lymph nodes: at the intersection of cancer treatment and progression. Trends Cell Biol. 2023;33:1021\u201334.","journal-title":"Trends Cell Biol"},{"key":"5864_CR13","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","volume":"376","author":"MB Faries","year":"2017","unstructured":"Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, et al. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. N Engl J Med. 2017;376:2211\u201322.","journal-title":"N Engl J Med"},{"key":"5864_CR14","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/SLA.0000000000004345","volume":"272","author":"RS Sippel","year":"2020","unstructured":"Sippel RS, Robbins SE, Poehls JL, Pitt SC, Chen H, Leverson G, Long KL, Schneider DF, Connor NP. A Randomized Controlled Clinical Trial: no Clear Benefit to Prophylactic Central Neck dissection in patients with clinically Node negative papillary thyroid Cancer. Ann Surg. 2020;272:496\u2013503.","journal-title":"Ann Surg"},{"key":"5864_CR15","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, et al. Effect of Axillary Dissection vs no Axillary dissection on 10-Year overall survival among women with invasive breast Cancer and Sentinel Node Metastasis: the ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318:918\u201326.","journal-title":"JAMA"},{"key":"5864_CR16","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/S0022-5347(01)62229-8","volume":"160","author":"AL Poulsen","year":"1998","unstructured":"Poulsen AL, Horn T, Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol. 1998;160:2015\u20139. discussion 2020.","journal-title":"J Urol"},{"key":"5864_CR17","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.eururo.2011.05.062","volume":"60","author":"H Abol-Enein","year":"2011","unstructured":"Abol-Enein H, Tilki D, Mosbah A, El-Baz M, Shokeir A, Nabeeh A, Ghoneim MA. Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study. Eur Urol. 2011;60:572\u20137.","journal-title":"Eur Urol"},{"key":"5864_CR18","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.eururo.2018.09.047","volume":"75","author":"JE Gschwend","year":"2019","unstructured":"Gschwend JE, Heck MM, Lehmann J, Rubben H, Albers P, Wolff JM, Frohneberg D, de Geeter P, Heidenreich A, Kalble T, et al. Extended Versus Limited Lymph Node dissection in bladder Cancer patients undergoing Radical Cystectomy: Survival results from a prospective, randomized trial. Eur Urol. 2019;75:604\u201311.","journal-title":"Eur Urol"},{"key":"5864_CR19","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1056\/NEJMoa2401497","volume":"391","author":"SP Lerner","year":"2024","unstructured":"Lerner SP, Tangen C, Svatek RS, Daneshmand S, Pohar KS, Skinner E, Schuckman A, Sagalowsky AI, Smith ND, Kamat AM, et al. Standard or extended lymphadenectomy for muscle-invasive bladder Cancer. N Engl J Med. 2024;391:1206\u201316.","journal-title":"N Engl J Med"},{"key":"5864_CR20","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","volume":"185","author":"Q Huang","year":"2022","unstructured":"Huang Q, Wu X, Wang Z, Chen X, Wang L, Lu Y, Xiong D, Liu Q, Tian Y, Lin H, et al. The primordial differentiation of tumor-specific memory CD8(+) T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes. Cell. 2022;185:4049\u2013e40664025.","journal-title":"Cell"},{"key":"5864_CR21","doi-asserted-by":"publisher","first-page":"eabg7836","DOI":"10.1126\/sciimmunol.abg7836","volume":"6","author":"KA Connolly","year":"2021","unstructured":"Connolly KA, Kuchroo M, Venkat A, Khatun A, Wang J, William I, Hornick NI, Fitzgerald BL, Damo M, Kasmani MY, et al. A reservoir of stem-like CD8(+) T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response. Sci Immunol. 2021;6:eabg7836.","journal-title":"Sci Immunol"},{"key":"5864_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","volume":"38","author":"F Dammeijer","year":"2020","unstructured":"Dammeijer F, van Gulijk M, Mulder EE, Lukkes M, Klaase L, van den Bosch T, van Nimwegen M, Lau SP, Latupeirissa K, Schetters S, et al. The PD-1\/PD-L1-Checkpoint restrains T cell immunity in Tumor-Draining Lymph Nodes. Cancer Cell. 2020;38:685\u2013e700688.","journal-title":"Cancer Cell"},{"key":"5864_CR23","doi-asserted-by":"crossref","unstructured":"Fransen MF, Schoonderwoerd M, Knopf P, Camps MG, Hawinkels LJ, Kneilling M, van Hall T, Ossendorp F. Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy. JCI Insight 2018, 3.","DOI":"10.1172\/jci.insight.124507"},{"key":"5864_CR24","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/s41416-021-01554-z","volume":"125","author":"CR Silvers","year":"2021","unstructured":"Silvers CR, Messing EM, Miyamoto H, Lee YF. Tenascin-C expression in the lymph node pre-metastatic niche in muscle-invasive bladder cancer. Br J Cancer. 2021;125:1399\u2013407.","journal-title":"Br J Cancer"},{"key":"5864_CR25","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.4049\/jimmunol.2100026","volume":"208","author":"PR Dominguez-Gutierrez","year":"2022","unstructured":"Dominguez-Gutierrez PR, Kwenda EP, Donelan W, Miranda M, Doty A, O\u2019Malley P, Crispen PL, Kusmartsev S. Detection of PD-L1-Expressing myeloid cell clusters in the Hyaluronan-enriched stroma in Tumor tissue and tumor-draining lymph nodes. J Immunol. 2022;208:2829\u201336.","journal-title":"J Immunol"},{"key":"5864_CR26","doi-asserted-by":"publisher","first-page":"1235812","DOI":"10.3389\/fimmu.2023.1235812","volume":"14","author":"C Viudez-Pareja","year":"2023","unstructured":"Viudez-Pareja C, Kreft E, Garcia-Caballero M. Immunomodulatory properties of the lymphatic endothelium in the tumor microenvironment. Front Immunol. 2023;14:1235812.","journal-title":"Front Immunol"},{"key":"5864_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2021.02.010","volume":"505","author":"S Liu","year":"2021","unstructured":"Liu S, Chen X, Lin T. Lymphatic metastasis of bladder cancer: molecular mechanisms, diagnosis and targeted therapy. Cancer Lett. 2021;505:13\u201323.","journal-title":"Cancer Lett"},{"key":"5864_CR28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.eururo.2007.08.030","volume":"53","author":"MI Fernandez","year":"2008","unstructured":"Fernandez MI, Bolenz C, Trojan L, Steidler A, Weiss C, Alken P, Grobholz R, Michel MS. Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder. Eur Urol. 2008;53:571\u20138.","journal-title":"Eur Urol"},{"key":"5864_CR29","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/onc.2017.184","volume":"36","author":"WX Peng","year":"2017","unstructured":"Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36:5661\u20137.","journal-title":"Oncogene"},{"key":"5864_CR30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1172\/JCI130892","volume":"130","author":"C Chen","year":"2020","unstructured":"Chen C, Luo Y, He W, Zhao Y, Kong Y, Liu H, Zhong G, Li Y, Li J, Huang J, et al. Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer. J Clin Invest. 2020;130:404\u201321.","journal-title":"J Clin Invest"},{"key":"5864_CR31","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1002\/ctm2.497","volume":"11","author":"H Zheng","year":"2021","unstructured":"Zheng H, Chen C, Luo Y, Yu M, He W, An M, Gao B, Kong Y, Ya Y, Lin Y, et al. Tumor-derived exosomal BCYRN1 activates WNT5A\/VEGF-C\/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer. Clin Transl Med. 2021;11:e497.","journal-title":"Clin Transl Med"},{"key":"5864_CR32","doi-asserted-by":"crossref","unstructured":"Chen C, Zheng H, Luo Y, Kong Y, An M, Li Y, He W, Gao B, Zhao Y, Huang H et al. SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer. J Clin Invest 2021, 131.","DOI":"10.1172\/JCI146431"},{"key":"5864_CR33","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ccell.2024.02.002","volume":"42","author":"H Zheng","year":"2024","unstructured":"Zheng H, An M, Luo Y, Diao X, Zhong W, Pang M, Lin Y, Chen J, Li Y, Kong Y, et al. PDGFRalpha(+)ITGA11(+) fibroblasts foster early-stage cancer lymphovascular invasion and lymphatic metastasis via ITGA11-SELE interplay. Cancer Cell. 2024;42:682\u2013e700612.","journal-title":"Cancer Cell"},{"key":"5864_CR34","doi-asserted-by":"publisher","first-page":"e12518","DOI":"10.1002\/jev2.12518","volume":"13","author":"Y Lin","year":"2024","unstructured":"Lin Y, Zheng H, Jia L, Luo Y, Zhang D, An M, Pang M, Diao X, Li W, Chen J, et al. Integrin alpha6-containing extracellular vesicles promote lymphatic remodelling for pre-metastatic niche formation in lymph nodes via interplay with CD151. J Extracell Vesicles. 2024;13:e12518.","journal-title":"J Extracell Vesicles"},{"key":"5864_CR35","doi-asserted-by":"publisher","first-page":"e0200079","DOI":"10.1371\/journal.pone.0200079","volume":"13","author":"CA Hartana","year":"2018","unstructured":"Hartana CA, Ahl\u00e9n Bergman E, Zirakzadeh AA, Krantz D, Winerdal ME, Winerdal M, Johansson M, Alamdari F, Jakubczyk T, Glise H, et al. Urothelial bladder cancer may suppress perforin expression in CD8\u2009+\u2009T cells by an ICAM-1\/TGF\u03b22 mediated pathway. PLoS ONE. 2018;13:e0200079.","journal-title":"PLoS ONE"},{"key":"5864_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12943-023-01899-4","volume":"22","author":"X Wu","year":"2023","unstructured":"Wu X, Li T, Jiang R, Yang X, Guo H, Yang R. Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects. Mol Cancer. 2023;22:194.","journal-title":"Mol Cancer"},{"key":"5864_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","volume":"581","author":"K Yamamoto","year":"2020","unstructured":"Yamamoto K, Venida A, Yano J, Biancur DE, Kakiuchi M, Gupta S, Sohn ASW, Mukhopadhyay S, Lin EY, Parker SJ, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:100\u20135.","journal-title":"Nature"},{"key":"5864_CR38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41467-022-35710-7","volume":"14","author":"W Lin","year":"2023","unstructured":"Lin W, Chen L, Zhang H, Qiu X, Huang Q, Wan F, Le Z, Geng S, Zhang A, Qiu S, et al. Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation. Nat Commun. 2023;14:265.","journal-title":"Nat Commun"},{"key":"5864_CR39","doi-asserted-by":"publisher","first-page":"e12926","DOI":"10.1111\/sji.12926","volume":"92","author":"D Krantz","year":"2020","unstructured":"Krantz D, Mints M, Winerdal M, Riklund K, Rutishauser D, Zubarev R, Zirakhzadeh AA, Alamdari F, Johansson M, Sherif A, Winqvist O. IL-16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity. Scand J Immunol. 2020;92:e12926.","journal-title":"Scand J Immunol"},{"key":"5864_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1684\/ecn.2021.0462","volume":"32","author":"A Ariafar","year":"2021","unstructured":"Ariafar A, Zareinejad M, Soltani M, Vahidi Y, Faghih Z. GM-CSF-producing lymphocytes in tumor-draining lymph nodes of patients with bladder cancer. Eur Cytokine Netw. 2021;32:1\u20137.","journal-title":"Eur Cytokine Netw"},{"key":"5864_CR41","first-page":"2237","volume":"54","author":"S Hori","year":"2019","unstructured":"Hori S, Miyake M, Onishi S, Morizawa Y, Nakai Y, Tatsumi Y, Onishi K, Iida K, Gotoh D, Itami Y, et al. Evaluation of pro\u2013 and anti\u2013tumor effects induced by three colony\u2013stimulating factors, G\u2013CSF, GM\u2013CSF and M\u2013CSF, in bladder cancer cells: is G\u2013CSF a friend of bladder cancer cells? Int J Oncol. 2019;54:2237\u201349.","journal-title":"Int J Oncol"},{"key":"5864_CR42","first-page":"147","volume":"13","author":"A Ariafar","year":"2024","unstructured":"Ariafar A, Mansourabadi Z, Rasekh S, Fakhimi M, Faghih Z. Diversity of memory CD8(+) T cells in Tumor-Draining Lymph nodes from patients with bladder Cancer. Int J Mol Cell Med. 2024;13:147\u201359.","journal-title":"Int J Mol Cell Med"},{"key":"5864_CR43","doi-asserted-by":"publisher","first-page":"e05556","DOI":"10.1016\/j.heliyon.2020.e05556","volume":"6","author":"A Ariafar","year":"2020","unstructured":"Ariafar A, Vahidi Y, Fakhimi M, Asadollahpour A, Erfani N, Faghih Z. Prognostic significance of CD4-positive regulatory T cells in tumor draining lymph nodes from patients with bladder cancer. Heliyon. 2020;6:e05556.","journal-title":"Heliyon"},{"key":"5864_CR44","first-page":"237","volume":"13","author":"Z Faghih","year":"2016","unstructured":"Faghih Z, Shobeiri SS, Ariafar A, Sarkarian M, Zeighami S, Nazari N, Abbasi-Sarvak S, Erfani N. CD8\u2009+\u2009T lymphocyte subsets in bladder tumor draining lymph nodes. Iran J Immunol. 2016;13:237\u201348.","journal-title":"Iran J Immunol"},{"key":"5864_CR45","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1159\/000474509","volume":"31","author":"E Reyes","year":"1997","unstructured":"Reyes E, Carballido J, Prieto A, Molto L, Manzano L, Alvarez-Mon M. T lymphocytes infiltrating the bladder wall of patients with carcinoma of urinary bladder are in vivo activated. Eur Urol. 1997;31:472\u20137.","journal-title":"Eur Urol"},{"key":"5864_CR46","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1159\/000471637","volume":"16","author":"H Tsujihashi","year":"1989","unstructured":"Tsujihashi H, Matsuda H, Uejima S, Akiyama T, Kurita T. Role of natural killer cells in bladder tumor. Eur Urol. 1989;16:444\u20139.","journal-title":"Eur Urol"},{"key":"5864_CR47","first-page":"121","volume":"21","author":"A Ariafar","year":"2024","unstructured":"Ariafar A, Kohansal E, Mousania A, Faghih Z. Natural killer cell subsets in Tumor draining Lymph nodes of patients with bladder Cancer and their clinical implications. Iran J Immunol. 2024;21:121\u201331.","journal-title":"Iran J Immunol"},{"key":"5864_CR48","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.cell.2023.02.020","volume":"186","author":"DJ Kloosterman","year":"2023","unstructured":"Kloosterman DJ, Akkari L. Macrophages at the interface of the co-evolving cancer ecosystem. Cell. 2023;186:1627\u201351.","journal-title":"Cell"},{"key":"5864_CR49","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1111\/cas.13565","volume":"109","author":"T Asano","year":"2018","unstructured":"Asano T, Ohnishi K, Shiota T, Motoshima T, Sugiyama Y, Yatsuda J, Kamba T, Ishizaka K, Komohara Y. CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis. Cancer Sci. 2018;109:1723\u201330.","journal-title":"Cancer Sci"},{"key":"5864_CR50","first-page":"1","volume":"15","author":"M Nagata","year":"2023","unstructured":"Nagata M, Ishizaka K, Asano T. CD169(+) macrophages residing in the draining lymph nodes and infiltrating the Tumor Play Opposite roles in the pathogenesis of bladder Cancer. Res Rep Urol. 2023;15:1\u20137.","journal-title":"Res Rep Urol"},{"key":"5864_CR51","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1002\/ijc.27506","volume":"131","author":"MB Maniecki","year":"2012","unstructured":"Maniecki MB, Etzerodt A, Ulhoi BP, Steiniche T, Borre M, Dyrskjot L, Orntoft TF, Moestrup SK, Moller HJ. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells. Int J Cancer. 2012;131:2320\u201331.","journal-title":"Int J Cancer"},{"key":"5864_CR52","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1172\/JCI21583","volume":"114","author":"DH Munn","year":"2004","unstructured":"Munn DH, Sharma MD, Hou D, Baban B, Lee JR, Antonia SJ, Messina JL, Chandler P, Koni PA, Mellor AL. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest. 2004;114:280\u201390.","journal-title":"J Clin Invest"},{"key":"5864_CR53","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976;116:180\u20133.","journal-title":"J Urol"},{"key":"5864_CR54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1470-2045(20)30540-4","volume":"22","author":"SA Boorjian","year":"2021","unstructured":"Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, et al. Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. Lancet Oncol. 2021;22:107\u201317.","journal-title":"Lancet Oncol"},{"key":"5864_CR55","doi-asserted-by":"publisher","first-page":"137ra172","DOI":"10.1126\/scitranslmed.3003586","volume":"4","author":"C Biot","year":"2012","unstructured":"Biot C, Rentsch CA, Gsponer JR, Birkhauser FD, Jusforgues-Saklani H, Lemaitre F, Auriau C, Bachmann A, Bousso P, Demangel C, et al. Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci Transl Med. 2012;4:137ra172.","journal-title":"Sci Transl Med"},{"key":"5864_CR56","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00262-011-1087-2","volume":"61","author":"G Codolo","year":"2012","unstructured":"Codolo G, Fassan M, Munari F, Volpe A, Bassi P, Rugge M, Pagano F, D\u2019Elios MM, de Bernard M. HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. Cancer Immunol Immunother. 2012;61:31\u201340.","journal-title":"Cancer Immunol Immunother"},{"key":"5864_CR57","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5301\/RU.2012.9189","volume":"79","author":"D D\u2019Agostino","year":"2012","unstructured":"D\u2019Agostino D, Racioppi M, Filianoti A, Di Gianfrancesco L, Codolo G, Fassan M, Munari F, Rugge M, D\u2019Elios MM, de Bernard M, et al. [Therapy for non-muscle invasive bladder cancer: HP-NAP]. Urologia. 2012;79:142\u20138.","journal-title":"Urologia"},{"key":"5864_CR58","first-page":"6956","volume":"63","author":"AS Yang","year":"2003","unstructured":"Yang AS, Monken CE, Lattime EC. Intratumoral vaccination with vaccinia-expressed tumor antigen and granulocyte macrophage colony-stimulating factor overcomes immunological ignorance to tumor antigen. Cancer Res. 2003;63:6956\u201361.","journal-title":"Cancer Res"},{"key":"5864_CR59","doi-asserted-by":"crossref","unstructured":"Sun M, Shi T, Tuerhong S, Li M, Wang Q, Lu C, Zou L, Zheng Q, Wang Y, Du J et al. An immunomodulator-boosted Lactococcus Lactis platform for enhanced in situ tumor vaccine. Adv Healthc Mater 2024:e2401635.","DOI":"10.1002\/adhm.202401635"},{"key":"5864_CR60","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1038\/s41467-022-35130-7","volume":"13","author":"J Zhu","year":"2022","unstructured":"Zhu J, Ke Y, Liu Q, Yang J, Liu F, Xu R, Zhou H, Chen A, Xiao J, Meng F, et al. Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy. Nat Commun. 2022;13:7466.","journal-title":"Nat Commun"},{"key":"5864_CR61","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00262-010-0852-y","volume":"59","author":"CH Huang","year":"2010","unstructured":"Huang CH, Chang CC, Lin CM, Wang ST, Wu MT, Li EI, Chang HC, Lin CC. Promoting effect of Antrodia Camphorata as an immunomodulating adjuvant on the antitumor efficacy of HER-2\/neu DNA vaccine. Cancer Immunol Immunother. 2010;59:1259\u201372.","journal-title":"Cancer Immunol Immunother"},{"key":"5864_CR62","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1158\/1078-0432.CCR-08-1988","volume":"15","author":"MC Yen","year":"2009","unstructured":"Yen MC, Lin CC, Chen YL, Huang SS, Yang HJ, Chang CP, Lei HY, Lai MD. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA. Clin Cancer Res. 2009;15:641\u20139.","journal-title":"Clin Cancer Res"},{"key":"5864_CR63","doi-asserted-by":"crossref","unstructured":"Bhatnagar S, Revuri V, Shah M, Larson P, Shao Z, Yu D, Prabha S, Griffith TS, Ferguson D, Panyam J. Combination of STING and TLR 7\/8 agonists as Vaccine adjuvants for Cancer Immunotherapy. Cancers (Basel) 2022, 14.","DOI":"10.3390\/cancers14246091"},{"key":"5864_CR64","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.biomaterials.2018.02.034","volume":"164","author":"H Kim","year":"2018","unstructured":"Kim H, Niu L, Larson P, Kucaba TA, Murphy KA, James BR, Ferguson DM, Griffith TS, Panyam J. Polymeric nanoparticles encapsulating novel TLR7\/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy. Biomaterials. 2018;164:38\u201353.","journal-title":"Biomaterials"},{"key":"5864_CR65","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-023-01492-8","volume":"16","author":"P Zhang","year":"2023","unstructured":"Zhang P, Zhang G, Wan X. Challenges and new technologies in adoptive cell therapy. J Hematol Oncol. 2023;16:97.","journal-title":"J Hematol Oncol"},{"key":"5864_CR66","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.eururo.2009.09.026","volume":"58","author":"A Sherif","year":"2010","unstructured":"Sherif A, Hasan MN, Marits P, Karlsson M, Winqvist O, Th\u00f6rn M. Feasibility of T-cell-based adoptive immunotherapy in the first 12 patients with advanced urothelial urinary bladder cancer. Preliminary data on a new immunologic treatment based on the sentinel node concept. Eur Urol. 2010;58:105\u201311.","journal-title":"Eur Urol"},{"key":"5864_CR67","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3109\/21681805.2015.1059880","volume":"49","author":"A Sherif","year":"2015","unstructured":"Sherif A, Hasan MN, Radecka E, Rodriguez AL, Shabo S, Karlsson M, Schumacher MC, Marits P, Winqvist O. Pilot study of adoptive immunotherapy with sentinel node-derived T cells in muscle-invasive urinary bladder cancer. Scand J Urol. 2015;49:453\u201362.","journal-title":"Scand J Urol"},{"key":"5864_CR68","doi-asserted-by":"publisher","first-page":"e1476816","DOI":"10.1080\/2162402X.2018.1476816","volume":"7","author":"M Poch","year":"2018","unstructured":"Poch M, Hall M, Joerger A, Kodumudi K, Beatty M, Innamarato PP, Bunch BL, Fishman MN, Zhang J, Sexton WJ, et al. Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer. Oncoimmunology. 2018;7:e1476816.","journal-title":"Oncoimmunology"},{"key":"5864_CR69","doi-asserted-by":"publisher","first-page":"628063","DOI":"10.3389\/fimmu.2021.628063","volume":"12","author":"AM Aydin","year":"2021","unstructured":"Aydin AM, Bunch BL, Beatty M, Hajiran A, Dhillon J, Sarnaik AA, Pilon-Thomas S, Poch MA. The factors affecting expansion of reactive tumor infiltrating lymphocytes (TIL) from bladder Cancer and potential therapeutic applications. Front Immunol. 2021;12:628063.","journal-title":"Front Immunol"},{"key":"5864_CR70","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.molimm.2020.05.010","volume":"124","author":"A Ariafar","year":"2020","unstructured":"Ariafar A, Ghaedi M, Rezaeifard S, Shahriari S, Zeighami S, Ghaderi A, Faghih Z. Clinical relevance and prognostic significance of PD-1\/PD-Ls in non-metastatic bladder cancer: a role for PD-L2. Mol Immunol. 2020;124:35\u201341.","journal-title":"Mol Immunol"},{"key":"5864_CR71","doi-asserted-by":"crossref","unstructured":"Zheng W, Zhang P, Yao C, Tao Y, Wang Z, Meng S. The clinical significance of PD-1 expression in patients with bladder cancer without lymph node metastasis: a comparative study with drained lymph nodes and tumor tissues. Int J Neurosci 2024:1\u201317.","DOI":"10.1080\/00207454.2024.2356152"},{"key":"5864_CR72","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/2326-6066.CIR-19-0826","volume":"8","author":"MM Leblond","year":"2020","unstructured":"Leblond MM, Till\u00e9 L, Nassiri S, Gilfillan CB, Imbratta C, Schmittnaegel M, Ries CH, Speiser DE, Verdeil G. CD40 agonist restores the Antitumor efficacy of Anti-PD1 therapy in muscle-invasive bladder Cancer in an IFN I\/II-Mediated manner. Cancer Immunol Res. 2020;8:1180\u201392.","journal-title":"Cancer Immunol Res"},{"key":"5864_CR73","doi-asserted-by":"crossref","unstructured":"Sato Y, Bolzenius JK, Eteleeb AM, Su X, Maher CA, Sehn JK, Arora VK. CD4\u2009+\u2009T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight 2018, 3.","DOI":"10.1172\/jci.insight.121062"},{"key":"5864_CR74","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1158\/2326-6066.CIR-13-0067","volume":"2","author":"LC Sandin","year":"2014","unstructured":"Sandin LC, Orlova A, Gustafsson E, Ellmark P, Tolmachev V, T\u00f6tterman TH, Mangsbo SM. Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer. Cancer Immunol Res. 2014;2:80\u201390.","journal-title":"Cancer Immunol Res"},{"key":"5864_CR75","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1158\/1078-0432.CCR-10-2888","volume":"17","author":"MF Fransen","year":"2011","unstructured":"Fransen MF, Sluijter M, Morreau H, Arens R, Melief CJ. Local activation of CD8 T cells and systemic tumor eradication without toxicity via slow release and local delivery of agonistic CD40 antibody. Clin Cancer Res. 2011;17:2270\u201380.","journal-title":"Clin Cancer Res"},{"key":"5864_CR76","doi-asserted-by":"crossref","unstructured":"Garris CS, Wong JL, Ravetch JV, Knorr DA. Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer. Sci Transl Med 2021, 13.","DOI":"10.1126\/scitranslmed.abd1346"},{"key":"5864_CR77","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00262-020-02746-x","volume":"70","author":"F Sadeghlar","year":"2021","unstructured":"Sadeghlar F, Vogt A, Mohr RU, Mahn R, van Beekum K, Kornek M, Weismuller TJ, Branchi V, Matthaei H, Toma M, et al. Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40\/CD40L on dendritic cells. Cancer Immunol Immunother. 2021;70:1451\u201364.","journal-title":"Cancer Immunol Immunother"},{"key":"5864_CR78","doi-asserted-by":"publisher","first-page":"8816","DOI":"10.1158\/1078-0432.CCR-05-1817","volume":"11","author":"AS Loskog","year":"2005","unstructured":"Loskog AS, Fransson ME, Totterman TT. AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model. Clin Cancer Res. 2005;11:8816\u201321.","journal-title":"Clin Cancer Res"},{"key":"5864_CR79","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1158\/1078-0432.CCR-10-0385","volume":"16","author":"PU Malmstrom","year":"2010","unstructured":"Malmstrom PU, Loskog AS, Lindqvist CA, Mangsbo SM, Fransson M, Wanders A, Gardmark T, Totterman TH. AdCD40L immunogene therapy for bladder carcinoma\u2013the first phase I\/IIa trial. Clin Cancer Res. 2010;16:3279\u201387.","journal-title":"Clin Cancer Res"},{"key":"5864_CR80","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/hep.22296","volume":"48","author":"MA Gonzalez-Carmona","year":"2008","unstructured":"Gonzalez-Carmona MA, Lukacs-Kornek V, Timmerman A, Shabani S, Kornek M, Vogt A, Yildiz Y, Sievers E, Schmidt-Wolf IG, Caselmann WH, et al. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo. Hepatology. 2008;48:157\u201368.","journal-title":"Hepatology"},{"key":"5864_CR81","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12967-017-1182-z","volume":"15","author":"A Schiza","year":"2017","unstructured":"Schiza A, Wenthe J, Mangsbo S, Eriksson E, Nilsson A, Totterman TH, Loskog A, Ullenhag G. Adenovirus-mediated CD40L gene transfer increases Teffector\/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients. J Transl Med. 2017;15:79.","journal-title":"J Transl Med"},{"key":"5864_CR82","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/neuonc\/noaa126","volume":"22","author":"P Wongthida","year":"2020","unstructured":"Wongthida P, Schuelke MR, Driscoll CB, Kottke T, Thompson JM, Tonne J, Stone C, Huff AL, Wetmore C, Davies JA, et al. Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors. Neuro Oncol. 2020;22:1757\u201370.","journal-title":"Neuro Oncol"},{"key":"5864_CR83","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","volume":"28","author":"L Galluzzi","year":"2015","unstructured":"Galluzzi L, Buque A, Kepp O, Zitvogel L, Kroemer G. Immunological effects of Conventional Chemotherapy and targeted Anticancer agents. Cancer Cell. 2015;28:690\u2013714.","journal-title":"Cancer Cell"},{"key":"5864_CR84","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.immuni.2013.06.014","volume":"39","author":"L Zitvogel","year":"2013","unstructured":"Zitvogel L, Galluzzi L, Smyth MJ, Kroemer G. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity. 2013;39:74\u201388.","journal-title":"Immunity"},{"key":"5864_CR85","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.eururo.2018.06.048","volume":"74","author":"D Krantz","year":"2018","unstructured":"Krantz D, Hartana CA, Winerdal ME, Johansson M, Alamdari F, Jakubczyk T, Huge Y, Aljabery F, Palmqvist K, Zirakzadeh AA, et al. Neoadjuvant Chemotherapy reinforces Antitumour T cell response in urothelial urinary bladder Cancer. Eur Urol. 2018;74:688\u201392.","journal-title":"Eur Urol"},{"key":"5864_CR86","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s00345-019-03025-w","volume":"38","author":"J Alvaeus","year":"2020","unstructured":"Alvaeus J, Rosenblatt R, Johansson M, Alamdari F, Jakubczyk T, Holmstr\u00f6m B, Hemdan T, Huge Y, Aljabery F, Gabrielsson S, et al. Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy. World J Urol. 2020;38:2207\u201313.","journal-title":"World J Urol"},{"key":"5864_CR87","doi-asserted-by":"publisher","first-page":"216740","DOI":"10.1016\/j.canlet.2024.216740","volume":"588","author":"ZY Xu","year":"2024","unstructured":"Xu ZY, Li ZZ, Cao LM, Zhong NN, Liu XH, Wang GR, Xiao Y, Liu B, Bu LL. Seizing the fate of lymph nodes in immunotherapy: to preserve or not? Cancer Lett. 2024;588:216740.","journal-title":"Cancer Lett"},{"key":"5864_CR88","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1158\/0008-5472.CAN-09-2982","volume":"70","author":"T Takeshima","year":"2010","unstructured":"Takeshima T, Chamoto K, Wakita D, Ohkuri T, Togashi Y, Shirato H, Kitamura H, Nishimura T. Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. Cancer Res. 2010;70:2697\u2013706.","journal-title":"Cancer Res"},{"key":"5864_CR89","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/cac2.12348","volume":"42","author":"Z Liu","year":"2022","unstructured":"Liu Z, Yu Z, Chen D, Verma V, Yuan C, Wang M, Wang F, Fan Q, Wang X, Li Y, et al. Pivotal roles of tumor-draining lymph nodes in the abscopal effects from combined immunotherapy and radiotherapy. Cancer Commun (Lond). 2022;42:971\u201386.","journal-title":"Cancer Commun (Lond)"},{"key":"5864_CR90","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1038\/s41467-022-31941-w","volume":"13","author":"R Saddawi-Konefka","year":"2022","unstructured":"Saddawi-Konefka R, O\u2019Farrell A, Faraji F, Clubb L, Allevato MM, Jensen SM, Yung BS, Wang Z, Wu VH, Anang NA, et al. Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC. Nat Commun. 2022;13:4298.","journal-title":"Nat Commun"},{"key":"5864_CR91","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/JS9.0000000000000774","volume":"110","author":"H Deng","year":"2024","unstructured":"Deng H, Zhou J, Chen H, Cai X, Zhong R, Li F, Cheng B, Li C, Jia Q, Zhou C, et al. Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study. Int J Surg. 2024;110:238\u201352.","journal-title":"Int J Surg"},{"key":"5864_CR92","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","volume":"186","author":"MK Rahim","year":"2023","unstructured":"Rahim MK, Okholm TLH, Jones KB, McCarthy EE, Liu CC, Yee JL, Tamaki SJ, Marquez DM, Tenvooren I, Wai K, et al. Dynamic CD8(+) T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. Cell. 2023;186:1127\u2013e11431118.","journal-title":"Cell"},{"key":"5864_CR93","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ccell.2024.05.015","volume":"42","author":"R Saddawi-Konefka","year":"2024","unstructured":"Saddawi-Konefka R, Schokrpur S, Gutkind JS. Let it be: preserving tumor-draining lymph nodes in the era of immuno-oncology. Cancer Cell. 2024;42:930\u20133.","journal-title":"Cancer Cell"},{"key":"5864_CR94","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1007\/s00262-021-02934-3","volume":"70","author":"VS Fear","year":"2021","unstructured":"Fear VS, Forbes CA, Neeve SA, Fisher SA, Chee J, Waithman J, Ma SK, Lake R, Nowak AK, Creaney J, et al. Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used. Cancer Immunol Immunother. 2021;70:3249\u201358.","journal-title":"Cancer Immunol Immunother"},{"key":"5864_CR95","doi-asserted-by":"crossref","unstructured":"Inamori K, Togashi Y, Fukuoka S, Akagi K, Ogasawara K, Irie T, Motooka D, Kobayashi Y, Sugiyama D, Kojima M et al. Importance of lymph node immune responses in MSI-H\/dMMR colorectal cancer. JCI Insight 2021, 6.","DOI":"10.1172\/jci.insight.137365"},{"key":"5864_CR96","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s00345-018-2306-7","volume":"36","author":"E Zaffuto","year":"2018","unstructured":"Zaffuto E, Bandini M, Gazdovich S, Valiquette AS, Leyh-Bannurah SR, Tian Z, Dell\u2019Oglio P, Graefen M, Moschini M, Necchi A, et al. Contemporary rates of adherence to international guidelines for pelvic lymph node dissection in radical cystectomy: a population-based study. World J Urol. 2018;36:1417\u201322.","journal-title":"World J Urol"},{"key":"5864_CR97","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41585-018-0066-1","volume":"15","author":"M Perera","year":"2018","unstructured":"Perera M, McGrath S, Sengupta S, Crozier J, Bolton D, Lawrentschuk N. Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer. Nat Rev Urol. 2018;15:686\u201392.","journal-title":"Nat Rev Urol"},{"key":"5864_CR98","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ejso.2014.10.061","volume":"41","author":"A Larcher","year":"2015","unstructured":"Larcher A, Sun M, Schiffmann J, Tian Z, Shariat SF, McCormack M, Saad F, Fossati N, Abdollah F, Briganti A, et al. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer. Eur J Surg Oncol. 2015;41:353\u201360.","journal-title":"Eur J Surg Oncol"},{"key":"5864_CR99","doi-asserted-by":"publisher","first-page":"E39","DOI":"10.1111\/bju.12371","volume":"113","author":"L Bi","year":"2014","unstructured":"Bi L, Huang H, Fan X, Li K, Xu K, Jiang C, Liu H, Dong W, Zhang S, Yang X, et al. Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis of comparative studies. BJU Int. 2014;113:E39\u201348.","journal-title":"BJU Int"},{"key":"5864_CR100","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1200\/JCO.2023.41.16_suppl.4508","volume":"41","author":"SP Lerner","year":"2023","unstructured":"Lerner SP, Tangen C, Svatek RS, Daneshmand S, Pohar KS, Skinner EC, Schuckman AK, Sagalowsky AI, Smith ND, Kamat AM, et al. SWOG S1011: a phase III surgical trial to evaluate the benefit of a standard versus an extended lymphadenectomy performed at time of radical cystectomy for muscle invasive urothelial cancer. J Clin Oncol. 2023;41:4508\u20134508.","journal-title":"J Clin Oncol"},{"key":"5864_CR101","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0022-5347(05)65284-6","volume":"167","author":"HW Herr","year":"2002","unstructured":"Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol. 2002;167:1295\u20138.","journal-title":"J Urol"},{"key":"5864_CR102","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1046\/j.1464-410x.2000.00614.x","volume":"85","author":"J Leissner","year":"2000","unstructured":"Leissner J, Hohenfellner R, Thuroff JW, Wolf HK. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int. 2000;85:817\u201323.","journal-title":"BJU Int"},{"key":"5864_CR103","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jamaoncol.2017.5553","volume":"4","author":"A Gupta","year":"2018","unstructured":"Gupta A, Moore JA, Lymphedema. JAMA Oncol. 2018;4:755\u2013755.","journal-title":"JAMA Oncol"},{"key":"5864_CR104","doi-asserted-by":"crossref","unstructured":"Flammia RS, Tuderti G, Bologna E, Minore A, Proietti F, Licari LC, Mastroianni R, Anceschi U, Brassetti A, Bove A et al. Assessing risk of lymph node invasion in complete responders to neoadjuvant chemotherapy for muscle-invasive bladder cancer. BJU Int 2024.","DOI":"10.1111\/bju.16440"},{"key":"5864_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.urology.2016.02.014","volume":"96","author":"B Kiss","year":"2016","unstructured":"Kiss B, Thoeny HC, Studer UE. Current status of Lymph Node Imaging in bladder and prostate Cancer. Urology. 2016;96:1\u20137.","journal-title":"Urology"},{"key":"5864_CR106","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ebiom.2018.03.034","volume":"31","author":"SX Wu","year":"2018","unstructured":"Wu SX, Huang J, Liu ZW, Chen HG, Guo P, Cai QQ, Zheng JJ, Qin HD, Zheng ZS, Chen X, et al. A genomic-clinicopathologic Nomogram for the preoperative prediction of Lymph Node Metastasis in bladder Cancer. EBioMedicine. 2018;31:54\u201365.","journal-title":"EBioMedicine"},{"key":"5864_CR107","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1470-2045(10)70296-5","volume":"12","author":"SC Smith","year":"2011","unstructured":"Smith SC, Baras AS, Dancik G, Ru Y, Ding KF, Moskaluk CA, Fradet Y, Lehmann J, Stockle M, Hartmann A, et al. A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment. Lancet Oncol. 2011;12:137\u201343.","journal-title":"Lancet Oncol"},{"key":"5864_CR108","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12885-015-1110-7","volume":"15","author":"W Liu","year":"2015","unstructured":"Liu W, Qi L, Lv H, Zu X, Chen M, Wang J, Liu L, Zeng F, Li Y. MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy. BMC Cancer. 2015;15:92.","journal-title":"BMC Cancer"},{"key":"5864_CR109","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S1470-2045(23)00061-X","volume":"24","author":"S Wu","year":"2023","unstructured":"Wu S, Hong G, Xu A, Zeng H, Chen X, Wang Y, Luo Y, Wu P, Liu C, Jiang N, et al. Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study. Lancet Oncol. 2023;24:360\u201370.","journal-title":"Lancet Oncol"},{"key":"5864_CR110","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41577-023-00965-8","volume":"24","author":"P Cruz de Casas","year":"2024","unstructured":"Cruz de Casas P, Knopper K, Dey Sarkar R, Kastenmuller W. Same yet different - how lymph node heterogeneity affects immune responses. Nat Rev Immunol. 2024;24:358\u201374.","journal-title":"Nat Rev Immunol"},{"key":"5864_CR111","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s40364-024-00643-4","volume":"12","author":"X Wu","year":"2024","unstructured":"Wu X, Yang X, Dai Y, Zhao Z, Zhu J, Guo H, Yang R. Single-cell sequencing to multi-omics: technologies and applications. Biomark Res. 2024;12:110.","journal-title":"Biomark Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05864-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05864-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05864-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:10:06Z","timestamp":1764331806000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05864-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5864"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05864-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"489"}}